Alex Zhavoronkov
Person ● Covered in 0 stories + Follow ✴ AI Graph Request update Wikipedia
Alex Zhavoronkov is the founder and CEO of Insilico Medicine. He works in biotechnology, regenerative medicine, and aging-related research, and his public profile places him in Cambridge, Massachusetts. His career has centered on AI for drug discovery and longevity research since 2014, leading to the creation of Insilico Medicine as a clinical-stage biotech company. He is known for his work on AI-driven drug discovery at Insilico Medicine and as an author on aging and biomedicine.
Updated 10 September 2026
Public sources: linkedin.com alexzhavoronkov.com Wikipedia
Why this page exists, and how to correct or remove it
This profile is assembled automatically because Alex Zhavoronkov appears in coverage we index or holds a role listed publicly by their organisation. It uses only public sources — company and organisation pages, news articles, Wikipedia, and public professional listings — and the biography, if any, is written by AI from those sources and cited above.
We hold it to report on the AI industry, under the legitimate interest of journalistic reporting. You can ask us to correct it, restrict it, or take it down, and you can object at any time — no account needed, no reason required.
Claim or correct this profile Request removal How we handle personal data